News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
488,993 Results
Type
Article (47440)
Company Profile (33)
Press Release (441520)
Section
Business (139469)
Career Advice (1175)
Deals (26402)
Drug Delivery (78)
Drug Development (63616)
Employer Resources (92)
FDA (12821)
Job Trends (11313)
News (247331)
Policy (25573)
Tag
Academia (2699)
Alliances (33996)
Alzheimer's disease (1105)
Approvals (12814)
Artificial intelligence (120)
Bankruptcy (270)
Best Places to Work (9073)
Breast cancer (182)
Cancer (1328)
Cardiovascular disease (105)
Career advice (959)
CAR-T (97)
Cell therapy (254)
Clinical research (51169)
Collaboration (466)
Compensation (98)
COVID-19 (2328)
C-suite (122)
Data (1301)
Diabetes (157)
Diagnostics (4908)
Earnings (51859)
Events (58870)
Executive appointments (452)
FDA (13502)
Funding (393)
Gene therapy (153)
GLP-1 (474)
Government (3462)
Healthcare (14745)
Infectious disease (2409)
Inflammatory bowel disease (94)
Interviews (190)
IPO (13211)
Job creations (2550)
Job search strategy (838)
Layoffs (345)
Legal (6361)
Lung cancer (205)
Lymphoma (89)
Manufacturing (188)
Medical device (9989)
Medtech (9991)
Mergers & acquisitions (13480)
Metabolic disorders (400)
Neuroscience (1409)
NextGen: Class of 2025 (4902)
Non-profit (3559)
Northern California (1418)
Obesity (209)
Parkinson's disease (86)
Patents (117)
People (44526)
Phase I (15303)
Phase II (22581)
Phase III (17520)
Pipeline (567)
Postmarket research (1932)
Preclinical (6470)
Radiopharmaceuticals (198)
Rare diseases (221)
Real estate (4485)
Regulatory (17116)
Research institute (1993)
Resumes & cover letters (196)
Southern California (1258)
Startups (2375)
United States (12880)
Vaccines (522)
Weight loss (145)
Date
Last 7 days (487)
Last 30 days (1964)
Last 365 days (26760)
2025 (2007)
2024 (27243)
2023 (30982)
2022 (38259)
2021 (44351)
2020 (43127)
2019 (34773)
2018 (26803)
2017 (24732)
2016 (22797)
2015 (27284)
2014 (19935)
2013 (16812)
2012 (17922)
2011 (18577)
2010 (16812)
Location
Africa (523)
Arizona (100)
Asia (29571)
Australia (5085)
California (3233)
Canada (1322)
China (281)
Colorado (170)
Connecticut (175)
Europe (62629)
Florida (534)
Georgia (114)
Illinois (335)
Indiana (193)
Japan (87)
Maryland (491)
Massachusetts (2235)
Michigan (162)
Minnesota (191)
New Jersey (1035)
New York (1027)
North Carolina (623)
Northern California (1418)
Ohio (114)
Pennsylvania (799)
South America (789)
Southern California (1258)
Texas (529)
Utah (98)
Washington State (367)
488,993 Results for "michigan state university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield® at the University of Michigan
January 7, 2025
·
4 min read
Pharm Country
NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan
NanoVibronix, Inc. (Nasdaq: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that the University of Michigan will begin the pilot phase of its clinical trial of UroShield this week.
May 22, 2024
·
4 min read
Press Releases
Vera Therapeutics Partners with University of Michigan on the NEPTUNE Match Project and PIONEER Study
November 11, 2024
·
7 min read
BioMidwest
Centene Subsidiary Meridian in Michigan Awarded Michigan Medicaid Contracts
Centene Corporation announced that its subsidiary, Meridian in Michigan, has been selected by the Michigan Department of Health and Human Services to continue to serve as a Medicaid health plan for the Comprehensive Health Care Program, which serves nearly 2 million Michiganders statewide.
April 9, 2024
·
10 min read
Business
Walden Biosciences Expands Research Collaboration with the University of Michigan
Walden Biosciences, Inc. today announced that it has broadened its research collaboration with the University of Michigan at Ann Arbor (U-M).
January 10, 2024
·
3 min read
Business
NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan
NanoVibronix, Inc. today announced it has signed a Research Agreement with the Regents of the University of Michigan for a Randomized Control Trial (“RCT”) study of UroShield.
November 28, 2023
·
4 min read
Drug Development
ASPIRE-FTD Phase 1/2 Clinical Trial Opens in the U.S. at The Ohio State University Wexner Medical Center
AviadoBio today announced that its Phase 1/2 ASPIRE-FTD clinical trial is now open and recruiting patients in the United States at The Ohio State University.
July 1, 2024
·
7 min read
Genetown
Activated University of Michigan as The Second Site for Clinical Trial in Severe Esophageal Disease
Harvard Apparatus Regenerative Technology, Inc. announced that it officially activated the second site with University of Michigan for its clinical trial as to severe esophageal disease, being its first clinical trial in the United States.
August 28, 2023
·
4 min read
Press Releases
Genprex Announces Sponsored Research Agreement with The University of Michigan Rogel Cancer Center and Lung Cancer Study Collaboration with ALK Positive
October 25, 2024
·
9 min read
Business
Tryp Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial for the Treatment of Fibromyalgia at The University of Michigan
Tryp Therapeutics Inc. is pleased to announce that the first patient has been dosed in a Phase 2a clinical trial being conducted by the University of Michigan in a collaboration with Tryp Therapeutics.
January 4, 2024
·
5 min read
1 of 48,900
Next
